IOM Committee Starts 'Omics Test Review | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Institute of Medicine has started a new committee that will look at predictive 'omics-based tests and eventually issue a report and recommendations on how to determine when these tests are fit for use as a basis for designing clinical trials, for stratifying patients, and measuring patient response in clinical trials.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.